Metropolitan Life Insurance CO Prothena Corp Public LTD CO Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$24.75 - $40.66 $1,782 - $2,927	-72 Reduced 3.01%	2,317 $57,000
Q3 2023 Nov 14, 2023	BUY	$47.3 - $70.6 $5,912 - $8,825	125 Added 5.52%	2,389 $115,000
Q2 2023 Aug 10, 2023	BUY	$48.26 - $78.59 $109,260 - $177,927	2,264 New	2,264 $154,000
Q4 2022 Jun 14, 2023	BUY	$52.05 - $65.0 $121,224 - $151,385	2,329 New	2,329 $140 Million
Q3 2022 Jun 14, 2023	BUY	$25.16 - $60.63 $58,597 - $141,207	2,329 New	2,329 $141 Million
Q2 2022 Jun 20, 2023	BUY	$22.73 - $39.98 $52,938 - $93,113	2,329 New	2,329 $63.2 Million
Q1 2022 Jun 20, 2023	BUY	$30.27 - $49.22 $70,498 - $114,633	2,329 New	2,329 $85.2 Million
Q4 2021 Jun 21, 2023	BUY	$42.11 - $73.26 $390,780 - $679,852	9,280 New	9,280 $458 Million
Q3 2021 Jun 21, 2023	BUY	$48.2 - $78.89 $447,296 - $732,099	9,280 New	9,280 $661 Million
Q1 2021 Jun 26, 2023	BUY	$11.0 - $28.24 $105,226 - $270,143	9,566 New	9,566 $240 Million
Q4 2020 Jun 22, 2023	BUY	$10.12 - $13.94 $100,602 - $138,577	9,941 New	9,941 $119 Million
Q3 2020 Jun 26, 2023	BUY	$9.93 - $13.47 $68,874 - $93,427	6,936 New	6,936 $69.3 Million
Q2 2020 Jun 26, 2023	BUY	$9.56 - $12.51 $121,937 - $159,565	12,755 New	12,755 $133 Million
Q1 2020 Jul 12, 2023	BUY	$7.54 - $15.77 $96,172 - $201,146	12,755 New	12,755 $136 Million
Q4 2019 Jul 12, 2023	BUY	$7.48 - $17.01 $89,041 - $202,487	11,904 New	11,904 $188 Million
Q3 2019 Jul 12, 2023	BUY	$6.89 - $10.45 $89,700 - $136,048	13,019 New	13,019 $102 Million
Q2 2019 Jul 12, 2023	BUY	$8.85 - $12.49 $115,218 - $162,607	13,019 New	13,019 $138 Million
Q1 2019 Jul 13, 2023	BUY	$10.32 - $14.49 $134,356 - $188,645	13,019 New	13,019 $158 Million
Q4 2018 Jul 13, 2023	BUY	$8.73 - $13.74 $113,655 - $178,881	13,019 New	13,019 $134 Million
Q3 2018 Jul 13, 2023	BUY	$12.7 - $15.79 $165,341 - $205,570	13,019 New	13,019 $170 Million

Others Institutions Holding PRTA

# of Institutions

184

Shares Held

42.7M

Call Options Held

162K

Put Options Held

102K

Eco R1 Capital, LLC San Francisco, CA

11.6M
Shares

$176 Million
8.41% of portfolio
Wellington Management Group LLP Boston, MA

4.18M
Shares

$63.6 Million
0.01% of portfolio
Black Rock Inc. New York, NY

3.86M
Shares

$58.7 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.82M
Shares

$58.2 Million
0.01% of portfolio
Palo Alto Investors LP Palo Alto, CA

1.74M
Shares

$26.5 Million
4.0% of portfolio

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $714M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account